Home/Filings/4/0001562180-24-008249
4//SEC Filing

Quane Alessandrea C. 4

Accession 0001562180-24-008249

CIK 0001568651other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 4:41 PM ET

Size

12.4 KB

Accession

0001562180-24-008249

Insider Transaction Report

Form 4
Period: 2024-12-05
Quane Alessandrea C.
EVP, Chief Insurance Officer
Transactions
  • Sale

    Class A Common Stock

    2024-12-06$15.93/sh10,385$165,433436,624 total
  • Exercise/Conversion

    Class A Common Stock

    2024-12-05+31,250447,009 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-12-0531,2500 total
    Class A Common Stock (31,250 underlying)
  • Sale

    Class A Common Stock

    2024-12-06$16.52/sh6,408$105,860430,216 total
Holdings
  • Class A Common Stock

    (indirect: Alessandrea C Quane 2024 GRAT)
    76,857
Footnotes (5)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
  • [F2]The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $16.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.40 to $16.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  • [F5]The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.

Issuer

Oscar Health, Inc.

CIK 0001568651

Entity typeother

Related Parties

1
  • filerCIK 0001667819

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:41 PM ET
Size
12.4 KB